Tumor cell-driven extracellular matrix remodeling enables haptotaxis during metastatic progression
Name
155627_2_merged_1453409214-1.pdf
Size
1.57 MB
Format
Adobe PDF
Checksum (MD5)
fba1b4bbc3fb86c81e1f112fcaaa8cd0
Author(s) • • • • • • • • •
Oudin, Madeleine Julie
Jonas, Oliver H.
Kosciuk, Tatsiana
Broye, Liliane C.
Candido Guido, Bruna
Wyckoff, Jeffrey
Asokan, Sreeja B.
Whittaker, Charles A.
Ma, Duanduan
Cima, Michael J.
Date Issued
January 2016
Journal
Cancer Discovery
Publisher
American Association for Cancer Research
Citation
Oudin, M. J., O. Jonas, T. Kosciuk, L. C. Broye, B. C. Guido, J. Wyckoff, D. Riquelme, et al. “Tumor Cell-Driven Extracellular Matrix Remodeling Enables Haptotaxis During Metastatic Progression.” Cancer Discovery (January 25, 2016).
Version
Author's final manuscript
Abstract
Fibronectin (FN) is a major component of the tumor microenvironment, but its role in promoting metastasis is incompletely understood. Here we show that FN gradients elicit directional movement of breast cancer cells, in vitro and in vivo. Haptotaxis on FN gradients requires direct interaction between α5β1 integrin and Mena, an actin regulator, and involves increases in focal complex signaling and tumor-cell-mediated extracellular matrix (ECM) remodeling. Compared to Mena, higher levels of the pro-metastatic MenaINV isoform associate with α5, which enables 3D haptotaxis of tumor cells towards the high FN concentrations typically present in perivascular space and in the periphery of breast tumor tissue. MenaINV and FN levels were correlated in two breast cancer cohorts, and high levels of MenaINV were significantly associated with increased tumor recurrence as well as decreased patient survival. Our results identify a novel tumor-cell-intrinsic mechanism that promotes metastasis through ECM remodeling and ECM guided directional migration.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1158/2159-8290.CD-15-1183